- Aug 07, 2018 Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results
- Aug 06, 2018 Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies
- Aug 03, 2018 CMS Grants New Technology Add-On Payment to Vyxeos® (daunorubicin and cytarabine) Liposome for Injection
- Jul 24, 2018 Jazz Pharmaceuticals to Report 2018 Second Quarter Financial Results on August 7, 2018
Data provided by Nasdaq. Minimum 15 minutes delayed.